Pharmacovigilance (PV) software-EMEA Market Status and Trend Report 2013-2023
Report Summary
Pharmacovigilance (PV) software-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Pharmacovigilance (PV) software industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole EMEA and Regional Market Size of Pharmacovigilance (PV) software 2013-2017, and development forecast 2018-2023
Main market players of Pharmacovigilance (PV) software in EMEA, with company and product introduction, position in the Pharmacovigilance (PV) software market
Market status and development trend of Pharmacovigilance (PV) software by types and applications
Cost and profit status of Pharmacovigilance (PV) software, and marketing status
Market growth drivers and challenges
The report segments the EMEA Pharmacovigilance (PV) software market as:
EMEA Pharmacovigilance (PV) software Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Europe
Middle East
Africa
EMEA Pharmacovigilance (PV) software Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Adverse Event Reporting Software
Drug Safety Audits Software
Issue Tracking Software
Fully Integrated Software
EMEA Pharmacovigilance (PV) software Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Pharma and Biotech Companies
Contract Research Organizations (CROs)
Business Process Outsourcing (BPO) Firms
Other Pharmacovigilance Service Providers
EMEA Pharmacovigilance (PV) software Market: Players Segment Analysis (Company and Product introduction, Pharmacovigilance (PV) software Sales Volume, Revenue, Price and Gross Margin):
ArisGlobal
Ennov Solutions Inc
EXTEDO GmbH
Online Business Applications, Inc
Oracle Corporation
Sarjen Systems Pvt. Ltd
Sparta Systems, Inc
United BioSource Corporation
AgilePV
AB cube
Max Application
Relsys
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Pharmacovigilance (PV) software-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Pharmacovigilance (PV) software industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole EMEA and Regional Market Size of Pharmacovigilance (PV) software 2013-2017, and development forecast 2018-2023
Main market players of Pharmacovigilance (PV) software in EMEA, with company and product introduction, position in the Pharmacovigilance (PV) software market
Market status and development trend of Pharmacovigilance (PV) software by types and applications
Cost and profit status of Pharmacovigilance (PV) software, and marketing status
Market growth drivers and challenges
The report segments the EMEA Pharmacovigilance (PV) software market as:
EMEA Pharmacovigilance (PV) software Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Europe
Middle East
Africa
EMEA Pharmacovigilance (PV) software Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Adverse Event Reporting Software
Drug Safety Audits Software
Issue Tracking Software
Fully Integrated Software
EMEA Pharmacovigilance (PV) software Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Pharma and Biotech Companies
Contract Research Organizations (CROs)
Business Process Outsourcing (BPO) Firms
Other Pharmacovigilance Service Providers
EMEA Pharmacovigilance (PV) software Market: Players Segment Analysis (Company and Product introduction, Pharmacovigilance (PV) software Sales Volume, Revenue, Price and Gross Margin):
ArisGlobal
Ennov Solutions Inc
EXTEDO GmbH
Online Business Applications, Inc
Oracle Corporation
Sarjen Systems Pvt. Ltd
Sparta Systems, Inc
United BioSource Corporation
AgilePV
AB cube
Max Application
Relsys
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF PHARMACOVIGILANCE (PV) SOFTWARE
1.1 Definition of Pharmacovigilance (PV) software in This Report
1.2 Commercial Types of Pharmacovigilance (PV) software
1.2.1 Adverse Event Reporting Software
1.2.2 Drug Safety Audits Software
1.2.3 Issue Tracking Software
1.2.4 Fully Integrated Software
1.3 Downstream Application of Pharmacovigilance (PV) software
1.3.1 Pharma and Biotech Companies
1.3.2 Contract Research Organizations (CROs)
1.3.3 Business Process Outsourcing (BPO) Firms
1.3.4 Other Pharmacovigilance Service Providers
1.4 Development History of Pharmacovigilance (PV) software
1.5 Market Status and Trend of Pharmacovigilance (PV) software 2013-2023
1.5.1 EMEA Pharmacovigilance (PV) software Market Status and Trend 2013-2023
1.5.2 Regional Pharmacovigilance (PV) software Market Status and Trend 2013-2023
CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Pharmacovigilance (PV) software in EMEA 2013-2017
2.2 Consumption Market of Pharmacovigilance (PV) software in EMEA by Regions
2.2.1 Consumption Volume of Pharmacovigilance (PV) software in EMEA by Regions
2.2.2 Revenue of Pharmacovigilance (PV) software in EMEA by Regions
2.3 Market Analysis of Pharmacovigilance (PV) software in EMEA by Regions
2.3.1 Market Analysis of Pharmacovigilance (PV) software in Europe 2013-2017
2.3.2 Market Analysis of Pharmacovigilance (PV) software in Middle East 2013-2017
2.3.3 Market Analysis of Pharmacovigilance (PV) software in Africa 2013-2017
2.4 Market Development Forecast of Pharmacovigilance (PV) software in EMEA 2018-2023
2.4.1 Market Development Forecast of Pharmacovigilance (PV) software in EMEA 2018-2023
2.4.2 Market Development Forecast of Pharmacovigilance (PV) software by Regions 2018-2023
CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole EMEA Market Status by Types
3.1.1 Consumption Volume of Pharmacovigilance (PV) software in EMEA by Types
3.1.2 Revenue of Pharmacovigilance (PV) software in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
3.2.1 Market Status by Types in Europe
3.2.2 Market Status by Types in Middle East
3.2.3 Market Status by Types in Africa
3.3 Market Forecast of Pharmacovigilance (PV) software in EMEA by Types
CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Pharmacovigilance (PV) software in EMEA by Downstream Industry
4.2 Demand Volume of Pharmacovigilance (PV) software by Downstream Industry in Major Countries
4.2.1 Demand Volume of Pharmacovigilance (PV) software by Downstream Industry in Europe
4.2.2 Demand Volume of Pharmacovigilance (PV) software by Downstream Industry in Middle East
4.2.3 Demand Volume of Pharmacovigilance (PV) software by Downstream Industry in Africa
4.3 Market Forecast of Pharmacovigilance (PV) software in EMEA by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF PHARMACOVIGILANCE (PV) SOFTWARE
5.1 EMEA Economy Situation and Trend Overview
5.2 Pharmacovigilance (PV) software Downstream Industry Situation and Trend Overview
CHAPTER 6 PHARMACOVIGILANCE (PV) SOFTWARE MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA
6.1 Sales Volume of Pharmacovigilance (PV) software in EMEA by Major Players
6.2 Revenue of Pharmacovigilance (PV) software in EMEA by Major Players
6.3 Basic Information of Pharmacovigilance (PV) software by Major Players
6.3.1 Headquarters Location and Established Time of Pharmacovigilance (PV) software Major Players
6.3.2 Employees and Revenue Level of Pharmacovigilance (PV) software Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 PHARMACOVIGILANCE (PV) SOFTWARE MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 ArisGlobal
7.1.1 Company profile
7.1.2 Representative Pharmacovigilance (PV) software Product
7.1.3 Pharmacovigilance (PV) software Sales, Revenue, Price and Gross Margin of ArisGlobal
7.2 Ennov Solutions Inc
7.2.1 Company profile
7.2.2 Representative Pharmacovigilance (PV) software Product
7.2.3 Pharmacovigilance (PV) software Sales, Revenue, Price and Gross Margin of Ennov Solutions Inc
7.3 EXTEDO GmbH
7.3.1 Company profile
7.3.2 Representative Pharmacovigilance (PV) software Product
7.3.3 Pharmacovigilance (PV) software Sales, Revenue, Price and Gross Margin of EXTEDO GmbH
7.4 Online Business Applications, Inc
7.4.1 Company profile
7.4.2 Representative Pharmacovigilance (PV) software Product
7.4.3 Pharmacovigilance (PV) software Sales, Revenue, Price and Gross Margin of Online Business Applications, Inc
7.5 Oracle Corporation
7.5.1 Company profile
7.5.2 Representative Pharmacovigilance (PV) software Product
7.5.3 Pharmacovigilance (PV) software Sales, Revenue, Price and Gross Margin of Oracle Corporation
7.6 Sarjen Systems Pvt. Ltd
7.6.1 Company profile
7.6.2 Representative Pharmacovigilance (PV) software Product
7.6.3 Pharmacovigilance (PV) software Sales, Revenue, Price and Gross Margin of Sarjen Systems Pvt. Ltd
7.7 Sparta Systems, Inc
7.7.1 Company profile
7.7.2 Representative Pharmacovigilance (PV) software Product
7.7.3 Pharmacovigilance (PV) software Sales, Revenue, Price and Gross Margin of Sparta Systems, Inc
7.8 United BioSource Corporation
7.8.1 Company profile
7.8.2 Representative Pharmacovigilance (PV) software Product
7.8.3 Pharmacovigilance (PV) software Sales, Revenue, Price and Gross Margin of United BioSource Corporation
7.9 AgilePV
7.9.1 Company profile
7.9.2 Representative Pharmacovigilance (PV) software Product
7.9.3 Pharmacovigilance (PV) software Sales, Revenue, Price and Gross Margin of AgilePV
7.10 AB cube
7.10.1 Company profile
7.10.2 Representative Pharmacovigilance (PV) software Product
7.10.3 Pharmacovigilance (PV) software Sales, Revenue, Price and Gross Margin of AB cube
7.11 Max Application
7.11.1 Company profile
7.11.2 Representative Pharmacovigilance (PV) software Product
7.11.3 Pharmacovigilance (PV) software Sales, Revenue, Price and Gross Margin of Max Application
7.12 Relsys
7.12.1 Company profile
7.12.2 Representative Pharmacovigilance (PV) software Product
7.12.3 Pharmacovigilance (PV) software Sales, Revenue, Price and Gross Margin of Relsys
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF PHARMACOVIGILANCE (PV) SOFTWARE
8.1 Industry Chain of Pharmacovigilance (PV) software
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF PHARMACOVIGILANCE (PV) SOFTWARE
9.1 Cost Structure Analysis of Pharmacovigilance (PV) software
9.2 Raw Materials Cost Analysis of Pharmacovigilance (PV) software
9.3 Labor Cost Analysis of Pharmacovigilance (PV) software
9.4 Manufacturing Expenses Analysis of Pharmacovigilance (PV) software
CHAPTER 10 MARKETING STATUS ANALYSIS OF PHARMACOVIGILANCE (PV) SOFTWARE
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Pharmacovigilance (PV) software in This Report
1.2 Commercial Types of Pharmacovigilance (PV) software
1.2.1 Adverse Event Reporting Software
1.2.2 Drug Safety Audits Software
1.2.3 Issue Tracking Software
1.2.4 Fully Integrated Software
1.3 Downstream Application of Pharmacovigilance (PV) software
1.3.1 Pharma and Biotech Companies
1.3.2 Contract Research Organizations (CROs)
1.3.3 Business Process Outsourcing (BPO) Firms
1.3.4 Other Pharmacovigilance Service Providers
1.4 Development History of Pharmacovigilance (PV) software
1.5 Market Status and Trend of Pharmacovigilance (PV) software 2013-2023
1.5.1 EMEA Pharmacovigilance (PV) software Market Status and Trend 2013-2023
1.5.2 Regional Pharmacovigilance (PV) software Market Status and Trend 2013-2023
CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Pharmacovigilance (PV) software in EMEA 2013-2017
2.2 Consumption Market of Pharmacovigilance (PV) software in EMEA by Regions
2.2.1 Consumption Volume of Pharmacovigilance (PV) software in EMEA by Regions
2.2.2 Revenue of Pharmacovigilance (PV) software in EMEA by Regions
2.3 Market Analysis of Pharmacovigilance (PV) software in EMEA by Regions
2.3.1 Market Analysis of Pharmacovigilance (PV) software in Europe 2013-2017
2.3.2 Market Analysis of Pharmacovigilance (PV) software in Middle East 2013-2017
2.3.3 Market Analysis of Pharmacovigilance (PV) software in Africa 2013-2017
2.4 Market Development Forecast of Pharmacovigilance (PV) software in EMEA 2018-2023
2.4.1 Market Development Forecast of Pharmacovigilance (PV) software in EMEA 2018-2023
2.4.2 Market Development Forecast of Pharmacovigilance (PV) software by Regions 2018-2023
CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole EMEA Market Status by Types
3.1.1 Consumption Volume of Pharmacovigilance (PV) software in EMEA by Types
3.1.2 Revenue of Pharmacovigilance (PV) software in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
3.2.1 Market Status by Types in Europe
3.2.2 Market Status by Types in Middle East
3.2.3 Market Status by Types in Africa
3.3 Market Forecast of Pharmacovigilance (PV) software in EMEA by Types
CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Pharmacovigilance (PV) software in EMEA by Downstream Industry
4.2 Demand Volume of Pharmacovigilance (PV) software by Downstream Industry in Major Countries
4.2.1 Demand Volume of Pharmacovigilance (PV) software by Downstream Industry in Europe
4.2.2 Demand Volume of Pharmacovigilance (PV) software by Downstream Industry in Middle East
4.2.3 Demand Volume of Pharmacovigilance (PV) software by Downstream Industry in Africa
4.3 Market Forecast of Pharmacovigilance (PV) software in EMEA by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF PHARMACOVIGILANCE (PV) SOFTWARE
5.1 EMEA Economy Situation and Trend Overview
5.2 Pharmacovigilance (PV) software Downstream Industry Situation and Trend Overview
CHAPTER 6 PHARMACOVIGILANCE (PV) SOFTWARE MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA
6.1 Sales Volume of Pharmacovigilance (PV) software in EMEA by Major Players
6.2 Revenue of Pharmacovigilance (PV) software in EMEA by Major Players
6.3 Basic Information of Pharmacovigilance (PV) software by Major Players
6.3.1 Headquarters Location and Established Time of Pharmacovigilance (PV) software Major Players
6.3.2 Employees and Revenue Level of Pharmacovigilance (PV) software Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 PHARMACOVIGILANCE (PV) SOFTWARE MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 ArisGlobal
7.1.1 Company profile
7.1.2 Representative Pharmacovigilance (PV) software Product
7.1.3 Pharmacovigilance (PV) software Sales, Revenue, Price and Gross Margin of ArisGlobal
7.2 Ennov Solutions Inc
7.2.1 Company profile
7.2.2 Representative Pharmacovigilance (PV) software Product
7.2.3 Pharmacovigilance (PV) software Sales, Revenue, Price and Gross Margin of Ennov Solutions Inc
7.3 EXTEDO GmbH
7.3.1 Company profile
7.3.2 Representative Pharmacovigilance (PV) software Product
7.3.3 Pharmacovigilance (PV) software Sales, Revenue, Price and Gross Margin of EXTEDO GmbH
7.4 Online Business Applications, Inc
7.4.1 Company profile
7.4.2 Representative Pharmacovigilance (PV) software Product
7.4.3 Pharmacovigilance (PV) software Sales, Revenue, Price and Gross Margin of Online Business Applications, Inc
7.5 Oracle Corporation
7.5.1 Company profile
7.5.2 Representative Pharmacovigilance (PV) software Product
7.5.3 Pharmacovigilance (PV) software Sales, Revenue, Price and Gross Margin of Oracle Corporation
7.6 Sarjen Systems Pvt. Ltd
7.6.1 Company profile
7.6.2 Representative Pharmacovigilance (PV) software Product
7.6.3 Pharmacovigilance (PV) software Sales, Revenue, Price and Gross Margin of Sarjen Systems Pvt. Ltd
7.7 Sparta Systems, Inc
7.7.1 Company profile
7.7.2 Representative Pharmacovigilance (PV) software Product
7.7.3 Pharmacovigilance (PV) software Sales, Revenue, Price and Gross Margin of Sparta Systems, Inc
7.8 United BioSource Corporation
7.8.1 Company profile
7.8.2 Representative Pharmacovigilance (PV) software Product
7.8.3 Pharmacovigilance (PV) software Sales, Revenue, Price and Gross Margin of United BioSource Corporation
7.9 AgilePV
7.9.1 Company profile
7.9.2 Representative Pharmacovigilance (PV) software Product
7.9.3 Pharmacovigilance (PV) software Sales, Revenue, Price and Gross Margin of AgilePV
7.10 AB cube
7.10.1 Company profile
7.10.2 Representative Pharmacovigilance (PV) software Product
7.10.3 Pharmacovigilance (PV) software Sales, Revenue, Price and Gross Margin of AB cube
7.11 Max Application
7.11.1 Company profile
7.11.2 Representative Pharmacovigilance (PV) software Product
7.11.3 Pharmacovigilance (PV) software Sales, Revenue, Price and Gross Margin of Max Application
7.12 Relsys
7.12.1 Company profile
7.12.2 Representative Pharmacovigilance (PV) software Product
7.12.3 Pharmacovigilance (PV) software Sales, Revenue, Price and Gross Margin of Relsys
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF PHARMACOVIGILANCE (PV) SOFTWARE
8.1 Industry Chain of Pharmacovigilance (PV) software
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF PHARMACOVIGILANCE (PV) SOFTWARE
9.1 Cost Structure Analysis of Pharmacovigilance (PV) software
9.2 Raw Materials Cost Analysis of Pharmacovigilance (PV) software
9.3 Labor Cost Analysis of Pharmacovigilance (PV) software
9.4 Manufacturing Expenses Analysis of Pharmacovigilance (PV) software
CHAPTER 10 MARKETING STATUS ANALYSIS OF PHARMACOVIGILANCE (PV) SOFTWARE
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
